NCT01998607View on ClinicalTrials.gov

Survey of XGEVA® Presrcibers in Europe to Evaluate Their Knowledge of the Summary of Product Characteristics Pertaining to Osteonecrosis of the Jaw

CompletedOBSERVATIONAL

Enrollment

420

Participants

Timeline

Start Date

February 4, 2013

Primary Completion Date

May 15, 2015

Study Completion Date

May 15, 2015

Conditions

Solid TumoursBone Metastasis

Interventions

OTHER

Physician Survey

Eligible physicians will be contacted to perform the physician survey. A standardised online questionnaire will be used to collect information about the physician's awareness of the Summary of Product characteristics (SPC) pertaining to osteonecrosis of the jaw (ONJ) in the last 6-18 months.